*John Ravits1 (1. University of California, San Diego)
Session information
Symposia
[4S05a] Update of oligonucleotide therapy as a major trend of drug discovery for intractable neurological diseases
Sun. Jul 3, 2022 2:00 PM - 4:00 PM Room 5 (Conference Building B2 (Okinawa Convention Center))
Chair: Takanori Yokota
*Chantal Ferguson Ferguson1,2, Julia Alterman1,2, Ken Yamada1,2, Dimas Echeverria1,2, Bruno Godinho1,2,3, Matthew Hassler1,2,3, Neil Aronin1,2,4, Anastasia Khvorova1,2,4 (1. University of Massachusetts Medical School, 2. RNA Therapeutics Institute, 3. Atalanta Therpeutics, 4. Department of Medicine)
*Tetsuya Nagata1 (1. Department of Neurology and Neurological Science, Tokyo Medical and Dental University)
*Tojo Nakayama1,2, Timothy W Yu1 (1. Harvard Medical School, Boston Children's Hospital, MA, USA, 2. Tokyo Medical and Dental University, Tokyo, Japan)